Correction

Topical Bimiralisib Shows Meaningful Cutaneous Drug Levels in Healthy Volunteers and Mycosis Fungoides Patients but No Clinical Activity in a First-in-Human, Randomized Controlled Trial (vol 14, 1510, 2022)

CANCERS (2023)

Volume 15, Issue 5, Pages -

DOI: 10.3390/cancers15051485

Click your name to claim this paper and add it to your profile.